申请人:AMGEN INC
公开号:WO2020132648A1
公开(公告)日:2020-06-25
Compounds of formula (I): (I), as defined herein, and synthetic intermediates thereof, which are capable of modulating KIF18A protein thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of KIF18A.
式(I)的化合物:(I),如本文所定义,并其合成中间体,能够调节KIF18A蛋白,从而影响细胞周期和细胞增殖过程,用于治疗癌症和癌症相关疾病。本发明还包括包括这些化合物的药物组合物,以及治疗与KIF18A活性相关的疾病状态的方法。